NIM
VERV

NEOS Investment Management’s Verve Therapeutics VERV Stock Holding History

NEOS Investment Management’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-95,029
Closed -$460K – 609
2024
Q3 		$460K Buy
95,029
+7,334
+8% +$42.6K 0.01% 503
2024
Q2 		$428K Buy
87,695
+47,014
+116% +$295K 0.02% 479
2024
Q1 		$540K Buy
40,681
+26,894
+195% +$357K 0.03% 363
2023
Q4 		$192K Buy
+13,787
New +$171K 0.02% 503

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

NEOS Investment Management's VERV Position: Q4 2024 in Review

NEOS Investment Management sold out of Verve Therapeutics (VERV) in Q4 2024, closing a stake of 95,029 shares — an estimated $460K sold.

NEOS Investment Management first reported a position in VERV in Q4 2023 and held it in 4 quarters. The position peaked at $540K in Q1 2024. 166 funds tracked by Wall St. Rank hold VERV as of Q4 2024.

  • NEOS Investment Management reported no remaining Verve Therapeutics position as of Q4 2024 after selling out during the quarter.
  • NEOS Investment Management sold 95,029 Verve Therapeutics shares in Q4 2024, an estimated $460K.
  • NEOS Investment Management first reported a position in Verve Therapeutics in Q4 2023 and held it in 4 quarters.
  • NEOS Investment Management's Verve Therapeutics position peaked at $540K in Q1 2024.
  • 166 funds tracked by Wall St. Rank held Verve Therapeutics as of Q4 2024.

Based on NEOS Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.